FDA orders all Juul e-cigarettes off the market
The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
Shots will be be available for children from 6 months to 5 years as early as next week.
The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
Shots will be be available for children from 6 months to 5 years as early as next week.
Shots will be be available for children from 6 months to 5 years as early as next week.
Shots will be be available for children from 6 months to 5 years as early as next week.
Shots will be be available for children from 6 months to 5 years as early as next week.
Shots will be be available for children from 6 months to 5 years as early as next week.
The companies plan to finish submitting data to the Food and Drug Administration this week.
The companies plan to finish submitting data to the Food and Drug Administration this week.
The companies plan to finish submitting data to the Food and Drug Administration this week.
The companies plan to finish submitting data to the Food and Drug Administration this week.
The companies plan to finish submitting data to the Food and Drug Administration this week.
The companies plan to finish submitting data to the Food and Drug Administration this week.
The companies plan to finish submitting data to the Food and Drug Administration this week.
The companies plan to finish submitting data to the Food and Drug Administration this week.
The companies plan to finish submitting data to the Food and Drug Administration this week.
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
The Biden administration has been eyeing boosters to keep vulnerable populations out of hospitals.
The Biden administration has been eyeing boosters to keep vulnerable populations out of hospitals.
The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.
The Biden administration has been eyeing boosters to keep vulnerable populations out of hospitals.
The company says its shot is safe, effective for youngest children.
The upcoming trials will test the drug at different doses for children as young as 6 years old who test positive for Covid-19 and are not hospitalized, but are also at risk of developing severe disease.
The upcoming trials will test the drug at different doses for children as young as 6 years old who test positive for Covid-19 and are not hospitalized, but are also at risk of developing severe disease.